A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial

Clinical trial NCT03344458 · COMPLETED

Trial details

NCT number: NCT03344458
Sponsor: Ascendis Pharma A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency, Pediatric Endocrine System Diseases Hormone Deficiency Pituitary Diseases

Start date: 2017-12-19
Primary completion: 2023-02-21
Enrollment: 298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.